Data / Form D filings / RenaBio Therapeutics, Inc.
RenaBio Therapeutics, Inc.: Form D filings
RenaBio Therapeutics, Inc., a health care company in Natick, MA, filed 2 Form D notices with the SEC between 2024 and 2025. The latest, on February 26, 2025, reports $250,000 sold of a $4.2 million offering to 1 investor.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- 22 STRATHMORE RD, #353, Natick, MA, 01760
- Phone
- (617) 721-0785
- Industry
- Other Health Care
- Entity type
- Corporation
- Incorporated in
- Delaware
- Year incorporated
- 2023
- Revenue range
- Decline to Disclose
- Exemptions claimed
- Rule 506(b)
- SEC identifier (CIK)
- 2018021
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| Feb 26, 2025 | New notice | $4,193,670 | $250,000 | $3,943,670 | 1 | Feb 20, 2025 | sec.gov |
| Apr 3, 2024 | New notice | $4,000,000 | $1,005,000 | $2,995,000 | 18 | Mar 28, 2024 | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| Zhenghua Wang | Director | |
| Yu (Zoe) Zhang | Director | |
| Hans Bitter | Director | |
| Jafari Mousa | Director | |
| Shengjun Ren | Executive Officer, Director |
Other health care companies in Massachusetts that filed recently
- XRHealth, Inc. $3.9 million · Oct 23, 2026
- Fresenius Medical Care Fulshear, LLC $4.4 million · Oct 21, 2026
- Nocturnal Inc. $1.9 million · Oct 20, 2026
- Mikri Inc. $1.4 million · Oct 19, 2026
- Soterya, Inc. $850,000 · Oct 13, 2026
- ArthroMeda, Inc. $8.7 million · Oct 13, 2026
Every Form D from the week of Feb 24, 2025 · All recent filings in Massachusetts · All recent Other Health Care filings
Read from SEC EDGAR. Amount sold is what RenaBio Therapeutics, Inc. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.